Cologne, Germany

Sebastian Knöbel

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Miltenyi Biotec B.v. & Co. Kg, Miltenyi Biotec B.v. Co., Kg, Miltenyi Biotec, Gmbh. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastian Knöbel. Retrieved from https://idiyas.com/inventor/sebastian-knobel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sebastian Knöbel: Innovator in Cell Protein Expression Profiling

Introduction

Sebastian Knöbel is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of cell protein expression profiling. His work is essential for advancing our understanding of dopaminergic progenitor cells.

Latest Patents

Sebastian Knöbel holds a patent for a method and kit for single cell protein expression profiling of floorplate mesencephalic dopaminergic progenitor cells. The patent describes an in-vitro method for analyzing a cell composition that includes human floorplate mesDA progenitor cells. The method involves labeling the cells with antigen binding molecules specific for certain antigens and determining the percentage of labeled cells. The cells qualify as human floorplate mesDA progenitor cells based on specific protein expression profiles.

Career Highlights

Sebastian Knöbel is currently employed at Miltenyi Biotec B.V. & Co. KG, where he continues to innovate in the field of biotechnology. His work has implications for research and therapeutic applications in neurobiology.

Collaborations

Sebastian collaborates with talented coworkers, including Melanie Jungblut and Andreas Bosio. Their combined expertise enhances the research and development efforts at Miltenyi Biotec.

Conclusion

Sebastian Knöbel's contributions to biotechnology, particularly through his patent on cell protein expression profiling, highlight his role as an innovator in the field. His work is paving the way for advancements in understanding dopaminergic progenitor cells.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…